Physician profile
John M Osborn
NPI 1518030659
$6,135.30
in general payments reported to CMS, 2019-2025
16 companies · $569 in 2025
The $569 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,088 · 2020: $1,766 · 2021: $588 · 2022: $1,051 · 2023: $616 · 2024: $456 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,642.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,641.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $1,898.99 | 2020-2025 | |
| Sientra, INC. | $819.83 | 2019-2022 | |
| Mentor Worldwide LLC | $755.83 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Integra Lifesciences Corporation | $597.77 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbvie INC. | $344.93 | 2023-2025 | |
| Allergan, INC. | $316.18 | 2019 | |
| Innovation Technologies INC | $253.62 | 2020-2024 | Irrisept |
| Baudax Bio INC. | $251.32 | 2021 | |
| Axogen | $188.21 | 2021 | |
| Kerecis Limited | $147.03 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Kci USA, INC. | $140.50 | 2023 | V.A.C. Veraflo |
| Baxter Healthcare | $122.18 | 2019-2021 | |
| Avita Medical Americas, LLC | $114.68 | 2024 | |
| Medtronic USA, INC. | $81.78 | 2020 | |
| Stryker Corporation | $75.48 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $26.97 | 2023 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Osborn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.